# The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices

Study · id `cardio:ct-nct03936647` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03936647](<https://clinicaltrials.gov/study/NCT03936647>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03936647

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

## Technical summary

Registry record NCT03936647. Randomized; no masking; primary purpose treatment. Start 2019-07-18 (actual); primary completion 2025-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT03936647, source copy `cardio:ctgov-nct03936647-2024-08-15`, retrieved 2026-11-18)
- Started: 2019-07-18 (actual) (ClinicalTrials.gov record NCT03936647, source copy `cardio:ctgov-nct03936647-2024-08-15`, retrieved 2026-11-18)
- Primary completion: 2025-01 (anticipated) (ClinicalTrials.gov record NCT03936647, source copy `cardio:ctgov-nct03936647-2024-08-15`, retrieved 2026-11-18)
- Completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT03936647, source copy `cardio:ctgov-nct03936647-2024-08-15`, retrieved 2026-11-18)
- Countries: Canada (ClinicalTrials.gov record NCT03936647, source copy `cardio:ctgov-nct03936647-2024-08-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03936647-2024-08-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices
- Acronym: RISE
- Condition: Intracranial Aneurysm
- Condition: Brain Aneurysm
- Condition: Unruptured Cerebral Aneurysm
- Condition: Ruptured Cerebral Aneurysm
- Condition: Cerebral Aneurysm
- Intervention (Procedure): surgical clipping, simple coiling, high-porosity stenting with/ without coiling, intra-arterial flow diversion with/ without coiling
- Intervention (Device): WEB embolization device
- Lead sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Centre hospitalier de l'Université de Montréal (CHUM) (`cardio:org-centre-hospitalier-de-l-universite-de-montreal-chum`)

## Provenance

Content hash: 5f5e917f2ddb71d1522ac31f796657771c3a01ff7a3257f6b8c2cc4f036a413d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
